|
|
Comprehensive Sterile Compounding
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding. Completion of the Fundamental Compounding & Calculations Course is recommended, but not required. Physicians and other health care professionals are welcome to attend.
Participants are instructed in the proper technique preparation, and quality control tests for sterile products, such as validation testing, membran... |
|
|
Therapeutic Update 2019 in Las Vegas
Sessions 1 & 2: New Drug Update Parts 1 & 2
At the completion of this activity, the participant will be able to:
Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
Describe their adverse effects and drug interaction that may affect patient compliance.
Compare efficacy, dosage ... |
|
|
Therapeutic Update 2019 in Key West
Sessions 1 & 2: New Drug Update Parts 1 & 2
At the completion of this activity, the participant will be able to:
Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
Describe their adverse effects and drug interaction that may affect patient compliance.
Compare efficacy, dosage ... |
|
|
Direct-Acting Oral Anticoagulants
This issue will review the evidence supporting DOACs and their place in therapy for: 1) atrial fibrillation (AF); 2) the acute treatment and long-term secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE); and 3) DVT and PE prevention after major orthopedic surgery and in medically ill patients. The differences among DOACs will be highlighted (eg, side effect profiles, dosing considerations and drug interactions), and DOACs will be compared with warfarin for conditions... |
|
|
Compounding for Hormone Replacement Therapy
COMPOUNDING FOR HORMONE REPLACEMENT THERAPY is an accredited 15 hour (1.5 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who want to learn more about a growing segment for compounding. Physicians and other healthcare professionals are welcome to attend. Using the basic components of compounding, HRT can be the cornerstone of a successful pharmacy with a diversified practice. Participants will gain a comprehensive knowledge of how and why a patient an... |
|
|
Compounding for Hormone Replacement Therapy
COMPOUNDING FOR HORMONE REPLACEMENT THERAPY is an accredited 15 hour (1.5 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who want to learn more about a growing segment for compounding. Physicians and other healthcare professionals are welcome to attend. Using the basic components of compounding, HRT can be the cornerstone of a successful pharmacy with a diversified practice. Participants will gain a comprehensive knowledge of how and why a patient an... |
|
|
Dermatological Compounding with Pain Management
DERMATOLOGICAL COMPOUNDING WITH PAIN MANAGEMENT is a 15 hour practice-based course designed for pharmacists, technicians, marketers, and students who want to learn more about a growing segment for compounding. Physicians and other healthcare professionals are welcome to attend. This course is a combination of didactic lectures for content and laboratory activities to enhance skill of compounding. Topics covered include: eczema, dermatitis, psoriasis, acne vulgaris, acne rosacea, cutaneous inf... |
|
|
Bariatric Home Study
In 2015-16 obesity affected over 93 million adults in the United States — nearly 2 out of every 5 Americans aged 20 and older. Community pharmacies interact with patients with obesity on a nearly daily basis and have an unparalleled opportunity to reach this market with critical health services.
The primary focus of this home study is to educate the community pharmacist on the medical and support needs and of the patient who is evaluating, undergoing, and/or completed bariatric weight-los... |
|
|
Sterile Compounding: USP Chapter Home Study
This is a home study program designed to introduce participants to current version of USP Chapter . USP Chapter describes the minimum practices and quality standards to be followed when preparing compounded sterile human and animal preparations (CSPs).
This 20-hour home study is an optional companion to the Comprehensive Sterile Compounding course for technicians and pharmacists. After successful completion of the two courses, the participant will have earned 40.0 hours of Sterile Compound... |
|
|
Basic Compounding and Calculations Home Study
The overall goal of this 12-hour knowledge based program is to provide the pharmacist and technician with a review of the calculations they will need to make in order to prepare the variety of medications their patients may need to attain the greatest therapeutic actions from their medications with the fewest undesirable side effects.
Pharmacists and pharmacy technicians all compound medications at some level in their practice. A review of the major topics that will be included are the fol... |
|
|
Ditch Your PPI
Currently, Proton Pump Inhibitors (PPIs) are the 3rd highest selling drug class in the US with 113 million prescriptions each year and sales exceeding $14 billion.
However, most PPIs are indicated for only 4-8 weeks of use and should not be used for more than 42 days per year (three 14-day therapy courses).
• 53-69% of PPI use is for inappropriate indications
• Continued use of PPIs has serious side effects including gastric atrophy, rebound acid reflux, nutrient depletion, bone fra... |
|
|
Quality Compounding Summit
The Quality Compounding Summit, presented by ARL Bio Pharma and the American College of Apothecaries, brings together nationally-known speakers and exhibitors for an intensive focus on quality issues for sterile and non-sterile compounding pharmacists, owners, pharmacy technicians, and leaders within the compounding industry. |
|
|
HIV Pharmacy Online Certification Training Program
One of the great keys to success in your HIV Pharmacy Business is your staff, your frontline employees who are working directly with and caring for your patients on a daily basis. Your employees are the engine to your business and key to your success in your HIV Specialty. It is vital to have each and every staff member, including you, well trained. Untrained staff can ruin your reputation and destroy your business.
The MichRx HIV Pharmacy Online Certification Training Program is a practic... |
|
|
Veterinary Pharmacy Conference 2019
Join ACVP at the Annual Veterinary Pharmacy Conference.
Join us at the only national conference designed exclusively for community veterinary pharmacy. Ideal for both new and established veterinary pharmacy practices, this conference is designed for pharmacists and pharmacy technicians and presents the latest in clinical and practical topics, as well as ample opportunity to network with colleagues and exhibitors.
Continuing education credit from the Accreditation Council for Pharmacy E... |
|
|
Veterinary Compounding Essentials
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge of animal diseases where a... |
|
|
Veterinary Compounding Essentials
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge of animal diseases where a... |
|
|
Veterinary Compounding Essentials
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge of animal diseases where a... |
|
|
Veterinary Compounding Essentials
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge of animal diseases where a... |
|
|
Veterinary Compounding Essentials
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge of animal diseases where a... |
|
|
Comprehensive Sterile Compounding
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding. Completion of the Fundamental Compounding & Calculations Course is recommended, but not required. Physicians and other health care professionals are welcome to attend.
Participants are instructed in the proper technique preparation, and quality control tests for sterile products, such as validation testing, membran... |
|
|
Comprehensive Sterile Compounding
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding. Completion of the Fundamental Compounding & Calculations Course is recommended, but not required. Physicians and other health care professionals are welcome to attend.
Participants are instructed in the proper technique preparation, and quality control tests for sterile products, such as validation testing, membran... |
|
|
Comprehensive Sterile Compounding
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding. Completion of the Fundamental Compounding & Calculations Course is recommended, but not required. Physicians and other health care professionals are welcome to attend.
Participants are instructed in the proper technique preparation, and quality control tests for sterile products, such as validation testing, membran... |
|
|
Comprehensive Sterile Compounding
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding. Completion of the Fundamental Compounding & Calculations Course is recommended, but not required. Physicians and other health care professionals are welcome to attend.
Participants are instructed in the proper technique preparation, and quality control tests for sterile products, such as validation testing, membran... |
|
|
Fundamental Compounding
FUNDAMENTAL COMPOUNDING is an accredited 3-day, 21-hour (2.1 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend.
This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn... |
|
|
Fundamental Compounding
FUNDAMENTAL COMPOUNDING is an accredited 3-day, 21-hour (2.1 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend.
This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn... |
|
|
Fundamental Compounding
FUNDAMENTAL COMPOUNDING is an accredited 3-day, 21-hour (2.1 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend.
This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn... |
|
|
Fundamental Compounding
FUNDAMENTAL COMPOUNDING is an accredited 3-day, 21-hour (2.1 CEUs) practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend.
This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn... |
|
|
Biologics for Severe Asthma: Case-Based Conversations
This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma. |
|
|
BLOCK HIV/HCV
Approximately 25% of all individuals infected with HIV are coinfected with HCV.1 Of critical significance, HIV increases the rate of progression of HCV-related hepatic fibrosis, and HCV is associated with a 3-fold increase in HIV antiretroviral therapy-induced liver toxicity.2 Further, these synergistic diseases often occur in adverse socioeconomic conditions that significantly increase the vulnerability and decrease the overall health status of at-risk populations.3 Whereas HIV infection is n... |
|
|
Looking at the Big Picture of IBD
The burden of inflammatory bowel diseases (IBD), of which Chroh's disease and ulcerative colitis are the primary entities, is significant and wide ranging. IBD that is not well-controlled impairs quality of life, social activities, travel and ability to work, leading to higher rates of absenteeism and permanent work disability.1,2 The idiopathic intestinal inflammation of IBD requires life-long treatment and accounts for enormous hospitalization costs. According to data from the U.S. Nationa... |
|
|
JAK Inhibition in Rheumatoid Arthritis
With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider. |
|
|
JAK Inhibition in Inflammatory Bowel Disease
This activity has been designed to meet the educational needs of gastroenterologists and rheumatologists who care for patients with inflammatory bowel disease or rheumatoid arthritis. |
|
|
JAK-STAT Signaling and Disease Pathogenesis in RA and IBD
With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider. |
|
|
Raising the Bar by Lowering the Target
This CME-accredited CME Snapshot™ highlights program compiles the key takeaways from a seven-part series intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During this activity, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience with identifying and managin... |
|
|
Pharmacoeconomic Outcomes of Suboptimal LDL-C Management
This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholestero... |
|
|
Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles
This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholestero... |
|
|
Diabetes Update 2019
The Comprehensive Harvard Medical School Diabetes Update
This Harvard Medical School CME program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.
• Expert guidance to design comprehensive treatment programs (non-pharmacological and pharmacological) for patients with diabetes
• Guidance to account for biological, psychological, emotional, social, financial and cult... |
|
|
TKI Therapy in CML: Emerging Treatments, Ensuring Safety
This Virtual Practice summarizes advances in tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) in the context of disease- and patient-specific characteristics; reviews the most effective methods for monitoring early response and long-term therapeutic outcomes; assesses the milestones and mutational analyses to identify when a change in TKI therapy is needed; compares toxicity profiles of the currently available TKI agents; and examines how toxicity could interact with... |
|
|
Managing Chronic Pain
Chronic pain management is a global health priority. Millions of adults (11%-19% of the US population) suffer daily from chronic, noncancer pain. A conservative estimate of the economic burden of pain in the US, including both healthcare costs and lost work productivity, is $560 - $635 billion annually. Most patients use a combination of non-drug approaches and medication to help alleviate pain. Although all drug treatments have risks that must be carefully weighed against the potential benefi... |
|
|
Collaborating with Patients to Reduce Long-Term Hypercholesterolemia Risks
This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles... |
|
|
Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles
This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles... |
|
|
Pharmacoeconomic Outcomes of Suboptimal LDL-C Management
This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles... |
|
|
Clinical Issues in Rheumatoid Arthritis: Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can cause bone and cartilage damage and lead to disability.1 RA affects about 24.5 million people, with 5 and 50 per 100,000 people newly developing the condition each year.1,2 RA has resulted in increased mortality in recent years, creating a need for an understanding of treat-to-target recommendations and appropriate disease activity measures.3 Adopting treat-to-target strategies in RA patients has shown great promise in ... |
|
|
Update on Indications, Interactions and Complications in the Use of Pharmaceuticals Alaska Cruise
1. Drug Abuse and Misuse
2. Understanding Patient’s Approaches in Self-Care
3. Optimizing Medication Adherence and Outcomes
4. From Pharmacogenomics to Personalized Medicine
5. Comprehensive Medication Management Services
6. Pharmaceutical Regulatory Update, Key Product Approvals, Guideline Updates |
|
|
Clinical Profiles of Current and Emerging GLP-1 RAs (Module 1 of 4)
This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ... |
|
|
Through Your Patient’s Eyes™ - Comprehensive Relief from Cancer Pain: Expanding the Conversation on Opioid-Induced Constipation
Despite a growing number of specific treatment options, many patients with cancer pain still suffer from opioid-induced constipation (OIC).1-3 Open communication among patients, caregivers, and treating clinicians is essential to determine the severity and psychosocial consequences of OIC.1-4 Patients with cancer pain and their proxies, however, are often reluctant to discuss opioid-related gastrointestinal symptoms and effects on quality of life. To address this barrier, clinicians should pro... |
|
|
Tailoring Long-Term Maintenance Regimens for Severe Asthma
This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma. |
|
|
Guidelines on Severe Asthma: A Practical Synthesis for Specialists
This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma. |
|
|
The Nexus of NASH and T2DM: The Emerging Role of the Diabetologist
NAFLD is a spectrum of potentially progressive liver disorders, ranging from simple hepatic steatosis to such severe forms as NASH, fibrosis, and cirrhosis.1 The prevalence rates of both NAFLD and NASH have been steadily trending upwards for years, mirroring the rapid and well-documented expansions of patient populations with obesity and/or T2DM.2-4 Thus, in the coming decade, burdens associated with this under-recognized epidemic are likely to increase exponentially for patients, clinicians, ... |
|
|
Inhibition of IL-6 Signaling in the Management of Rheumatoid Arthritis
This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interl... |
|